Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study Between September 2015 and March 2017, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results